Background Precise estimates of mortality in Staphylococcus aureus bacteraemia (SAB) are
important to convey prognosis and guide the design of interventional studies. Objectives We …

Staphylococcus aureus is a member of the human commensal microflora that exists,
apparently benignly, at multiple sites on the host. However, as an opportunist pathogen it …

Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Staphylococcus aureus bacteremia (SAB) is an important infection with an incidence rate
ranging from 20 to 50 cases/100,000 population per year. Between 10% and 30% of these …

Staphylococcus aureus is an important cause of skin and soft-tissue infections (SSTIs),
endovascular infections, pneumonia, septic arthritis, endocarditis, osteomyelitis, foreign …

Staphylococcus aureus is notorious for its ability to become resistant to antibiotics. Infections
that are caused by antibiotic-resistant strains often occur in epidemic waves that are initiated …

Meticillin-resistant Staphylococcus aureus (MRSA) is endemic in hospitals worldwide, and
causes substantial morbidity and mortality. Health-care-associated MRSA infections arise in …

Background Diabetes prevalence is increasing globally, and Sub-Saharan Africa is no
exception. With diverse health challenges, health authorities in Sub-Saharan Africa and …

Staphylococcus aureus has been an important human pathogen throughout history and is
currently a leading cause of bacterial infections worldwide. S. aureus has the unique ability …

Bloodstream infection (BSI) is associated with major morbidity and mortality. Population-
based studies are the optimal designs to determine the occurrence of BSI. This is because in …